07th November 2025 The Central Drugs Standard Control Organisation (CDSCO) has issued a directive to all State Licensing Authorities (SLAs) to conduct inspections of pharmaceutical manufacturing firms in accordance with the Revised Schedule M requirements. As per the notice…
Recent Post
- Schedule H2 Expanded: Antimicrobials and Many Other Drugs Now Under Stricter Controls
- CDSCO Restricts IVF Supplies to Registered ART Centres
- CDSCO Issues Clarity on New Drugs, DC Granules & MR Pellets Licensing
- Centre Bans 16 Fixed Dose Combinations Under Section 26A of Drugs & Cosmetics Act
- India Cracks Down on Chloramphenicol & Nitrofurans in Food Producing Animals
